Literature DB >> 21194023

Phenotyping cardiac gene therapy in mice.

Brian Bostick1, Yongping Yue, Dongsheng Duan.   

Abstract

Heart disease is the leading health problem of industrialized countries. The development of gene therapies tailored towards the heart has grown exponentially over the past decade. Murine models of heart diseases have played a pivotal role in testing novel cardiac gene therapy approaches. Unfortunately, the small body size and rapid heart rate of mice present a great challenge to heart function evaluation. Here we outline the commonly used cardiac phenotyping methods of treadmill exercise regimen, full 12-lead electrocardiographic assay and left ventricular catheterization hemodynamic assay. Application of these protocols will allow critical testing of gene therapy efficacy in mouse models of heart diseases.

Entities:  

Mesh:

Year:  2011        PMID: 21194023      PMCID: PMC3118042          DOI: 10.1007/978-1-61737-982-6_6

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  25 in total

1.  A treadmill exercise regimen for identifying cardiovascular phenotypes in transgenic mice.

Authors:  J G Fewell; H Osinska; R Klevitsky; W Ng; G Sfyris; F Bahrehmand; J Robbins
Journal:  Am J Physiol       Date:  1997-09

2.  Long-term telemetric measurement of cardiovascular parameters in awake mice: a physiological genomics tool.

Authors:  G M Butz; R L Davisson
Journal:  Physiol Genomics       Date:  2001-03-08       Impact factor: 3.107

3.  Invasive hemodynamics and force-frequency relationships in open- versus closed-chest mice.

Authors:  B D Hoit; N Ball; R A Walsh
Journal:  Am J Physiol       Date:  1997-11

4.  Hemodynamics of anesthetized ventilated mouse models: aspects of anesthetics, fluid support, and strain.

Authors:  Coert J Zuurbier; Vanessa M Emons; Can Ince
Journal:  Am J Physiol Heart Circ Physiol       Date:  2002-06       Impact factor: 4.733

5.  Potent metalloporphyrin peroxynitrite decomposition catalyst protects against the development of doxorubicin-induced cardiac dysfunction.

Authors:  Pál Pacher; Lucas Liaudet; Péter Bai; Jon G Mabley; Pawel M Kaminski; László Virág; Amitabha Deb; Eva Szabó; Zoltán Ungvári; Michael S Wolin; John T Groves; Csaba Szabó
Journal:  Circulation       Date:  2003-02-18       Impact factor: 29.690

Review 6.  Murine physiology: measuring the phenotype.

Authors:  Brian D Hoit
Journal:  J Mol Cell Cardiol       Date:  2004-08       Impact factor: 5.000

7.  Efficient and long-term intracardiac gene transfer in delta-sarcoglycan-deficiency hamster by adeno-associated virus-2 vectors.

Authors:  J Li; D Wang; S Qian; Z Chen; T Zhu; X Xiao
Journal:  Gene Ther       Date:  2003-10       Impact factor: 5.250

8.  Haemodynamic profile and responsiveness to anandamide of TRPV1 receptor knock-out mice.

Authors:  Pál Pacher; Sándor Bátkai; George Kunos
Journal:  J Physiol       Date:  2004-04-30       Impact factor: 5.182

9.  Effects of anesthetics on systemic hemodynamics in mice.

Authors:  Ben J A Janssen; Tijl De Celle; Jacques J M Debets; Agnieszka E Brouns; Michael F Callahan; Thomas L Smith
Journal:  Am J Physiol Heart Circ Physiol       Date:  2004-05-20       Impact factor: 4.733

10.  Microdystrophin gene therapy of cardiomyopathy restores dystrophin-glycoprotein complex and improves sarcolemma integrity in the mdx mouse heart.

Authors:  Yongping Yue; Zhenbo Li; Scott Q Harper; Robin L Davisson; Jeffrey S Chamberlain; Dongsheng Duan
Journal:  Circulation       Date:  2003-09-02       Impact factor: 29.690

View more
  17 in total

1.  AAV CRISPR editing rescues cardiac and muscle function for 18 months in dystrophic mice.

Authors:  Chady H Hakim; Nalinda B Wasala; Christopher E Nelson; Lakmini P Wasala; Yongping Yue; Jacqueline A Louderman; Thais B Lessa; Aihua Dai; Keqing Zhang; Gregory J Jenkins; Michael E Nance; Xiufang Pan; Kasun Kodippili; N Nora Yang; Shi-Jie Chen; Charles A Gersbach; Dongsheng Duan
Journal:  JCI Insight       Date:  2018-12-06

2.  Electrocardiographic Characterization of Cardiac Hypertrophy in Mice that Overexpress the ErbB2 Receptor Tyrosine Kinase.

Authors:  Polina Sysa-Shah; Lars L Sørensen; M Roselle Abraham; Kathleen L Gabrielson
Journal:  Comp Med       Date:  2015-08       Impact factor: 0.982

3.  AAV-microdystrophin therapy improves cardiac performance in aged female mdx mice.

Authors:  Brian Bostick; Jin-Hong Shin; Yongping Yue; Dongsheng Duan
Journal:  Mol Ther       Date:  2011-08-02       Impact factor: 11.454

4.  Single SERCA2a Therapy Ameliorated Dilated Cardiomyopathy for 18 Months in a Mouse Model of Duchenne Muscular Dystrophy.

Authors:  Nalinda B Wasala; Yongping Yue; William Lostal; Lakmini P Wasala; Nandita Niranjan; Roger J Hajjar; Gopal J Babu; Dongsheng Duan
Journal:  Mol Ther       Date:  2020-01-10       Impact factor: 11.454

5.  Genomic removal of a therapeutic mini-dystrophin gene from adult mice elicits a Duchenne muscular dystrophy-like phenotype.

Authors:  Nalinda B Wasala; Yi Lai; Jin-Hong Shin; Junling Zhao; Yongping Yue; Dongsheng Duan
Journal:  Hum Mol Genet       Date:  2016-04-22       Impact factor: 6.150

6.  Chronic β2 adrenergic agonist, but not exercise, improves glucose handling in older type 2 diabetic mice.

Authors:  Hamzeh Elayan; Milos Milic; Ping Sun; Munir Gharaibeh; Michael G Ziegler
Journal:  Cell Mol Neurobiol       Date:  2012-03-16       Impact factor: 5.046

7.  Cardiac-Specific Expression of ΔH2-R15 Mini-Dystrophin Normalized All Electrocardiogram Abnormalities and the End-Diastolic Volume in a 23-Month-Old Mouse Model of Duchenne Dilated Cardiomyopathy.

Authors:  Nalinda B Wasala; Jin-Hong Shin; Yi Lai; Yongping Yue; Federica Montanaro; Dongsheng Duan
Journal:  Hum Gene Ther       Date:  2018-03-22       Impact factor: 5.695

8.  Uniform low-level dystrophin expression in the heart partially preserved cardiac function in an aged mouse model of Duchenne cardiomyopathy.

Authors:  Nalinda B Wasala; Yongping Yue; Jenna Vance; Dongsheng Duan
Journal:  J Mol Cell Cardiol       Date:  2016-11-29       Impact factor: 5.000

9.  Coronary artery spasm related to thiol oxidation and senescence marker protein-30 in aging.

Authors:  Shinya Yamada; Shu-ichi Saitoh; Hirofumi Machii; Hiroyuki Mizukami; Yasuto Hoshino; Tomofumi Misaka; Akihito Ishigami; Yasuchika Takeishi
Journal:  Antioxid Redox Signal       Date:  2013-02-19       Impact factor: 8.401

10.  Exclusive skeletal muscle correction does not modulate dystrophic heart disease in the aged mdx model of Duchenne cardiomyopathy.

Authors:  Nalinda B Wasala; Brian Bostick; Yongping Yue; Dongsheng Duan
Journal:  Hum Mol Genet       Date:  2013-03-03       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.